Insights

Why BrainChip (ASX:BRN) is the best share to buy today

After its recent share price sell off, I think BrainChip has become the best share to buy on the ASX. Here is why this is a great opportunity.
The post Why BrainChip (ASX:BRN) is the best share to buy today appeared first on Motley Fool Australia. –

brainchip shares represented by illustration of a blue brain wearing a gold crown

BrainChip Holdings Ltd (ASX: BRN) saw its share price jump by 12.5% on Thursday, and it has risen by 620% in year-to-date trading. Despite this, I think this is the best share to buy on the ASX right now. It is an artificial intelligence company with existing products in security applications globally. Although all the company’s revenue is from security industries such as; casino play management, subways and international airports, it is still very much in start up mode.

Why is this the best share to buy?

The company is pioneering a first-of-a-kind neuromorphic chip called Akida, designed to replicate the human brain and sensory system. At this stage, it has been built and is in the early stages of prototype collaborations with carefully selected partners. These include United States-based Vorago Technologies for a Phase 1 NASA project, MagikEye Inc., and two auto manufacturers. The applications are very broad and the company is pushing us towards a future where many things suddenly become possible. 

The Akida chip has many applications throughout defence, with the initial focus on space and drone technology due to its many physical advantages. For instance, it has low energy requirements, is lightweight, and has the ability to take the place of multiple processors and components. 

Another reason I think BrainChip is currently the best share to buy is the highly diverse field of applications its product spans. These include autonomous vehicles, smart home applications, and speech and gesture recognition for gaming. 

BrainChip CEO, Louis DiNardo, recently said:

You don’t need a lot of market share to build a big company, so we’re being somewhat selective about our target markets and applications. And fortunately for us, after a lot of hard work, we now have chips in hand. It’s not just about PowerPoint presentations .. we’ve actually got chips.

The company expects to see Akida commercialisation start from early CY21 with customers licensing its intellectual property. This is expected to be followed by full-scale chip manufacturing towards the end of CY21. 

Foolish takeaway

BrainChip is in the late stages of product development and is, I believe, leading the world in this technology. Although not currently profitable, the company’s addressable market is massive. Moreover, as the capabilities of this technology become more widely known, its addressable market will expand further.

The BrainChip share price has risen and fallen dramatically over the past month. So even with a 12.5% pop in the share price yesterday, I still believe it remains the best share to buy on the ASX at the moment. It is a very rare opportunity for investors to buy into an ASX listed semiconductor company in its early stages. 

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of June 30th

More reading

Motley Fool contributor Daryl Mather has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Why BrainChip (ASX:BRN) is the best share to buy today appeared first on Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!